News

Combination gene therapy developed at Wyss Institute and Harvard Medical School treats four age-related conditions

Wyss Institute-launched startup company will develop probiotics that have potential to enhance athletic performance

New protocol produces large numbers of mature human podocytes, enabling kidney disease modeling, drug discovery, and potential cell therapies

Through a new license, Harvard lab’s innovations in genome engineering might solve the organ transplant shortage